BioLineRx Ltd. (BLRX)
NASDAQ: BLRX
· Real-Time Price · USD
3.66
-0.11 (-2.92%)
At close: Aug 15, 2025, 1:18 PM
-2.92% (1D)
| Bid | 3.63 |
| Market Cap | 292.27M |
| Revenue (ttm) | 22.34M |
| Net Income (ttm) | -3.4M |
| EPS (ttm) | -6 |
| PE Ratio (ttm) | -0.61 |
| Forward PE | -13.65 |
| Analyst | Buy |
| Ask | 3.8 |
| Volume | 15,645 |
| Avg. Volume (20D) | 696,853 |
| Open | 3.65 |
| Previous Close | 3.77 |
| Day's Range | 3.63 - 3.80 |
| 52-Week Range | 2.30 - 32.40 |
| Beta | 0.88 |
About BLRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BLRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BLRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
BioLineRx Ltd. is scheduled to release its earnings on
Nov 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+38.52%
BioLineRx shares are trading higher after the comp...
Unlock content with
Pro Subscription
7 months ago
-16.8%
BioLineRx shares are trading lower after the company announced a dilutive change in the ratio of American depositary shares to ordinary shares. The proposed exchange ratio is equivalent to a 1-for-40 basis reverse stock split.
